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Summary
Small cell lung cancer (SCLC) is a highly aggressive human tumor with a more than 95% mortality rate. Its ontogeny and
molecular pathogenesis remains poorly understood. We established a mouse model for neuroendocrine (NE) lung tumors
by conditional inactivation of Rb1 and Trp53 in mouse lung epithelial cells. Mice carrying conditional alleles for both
Rb1 and Trp53 developed with high incidence aggressive lung tumors with striking morphologic and immunophenotypic
similarities to SCLC. Most of these tumors, which we designate MSCLC (murine small cell lung carcinoma), diffusely spread
through the lung and gave rise to extrapulmonary metastases. In our model, inactivation of both Rb1 and p53 was a
prerequisite for the pathogenesis of SCLC.
Introduction et al., 2003). Together with retinoblastoma, SCLC is the only
human neural/neuroendocrine tumor that harbors RB1 muta-
Lung carcinoma is currently the most frequent cause of cancer tions in almost all cases (Sherr and McCormick, 2002). Chimeric
deaths (Tyczynski et al., 2003; Minna et al., 2002). Clinically and mice from Rb1/ ES cells and Rb1/ mice developed extrapul-
histopathologically, lung carcinomas are divided into two major monary NE tumors but no apparent lung lesions (Jacks et al.,
groups. Small cell lung carcinoma (SCLC), a highly malignant 1992; Maandag et al., 1994). On the other hand Rb1/;Trp53/
tumor of primitive neuroendocrine (NE) cells, is thought to arise mice used in previous studies developed a variety of primary
from cells residing in the epithelial lining of the bronchi which tumors of NE origin as well as focal bronchial NE cell hyperpla-
share the NE phenotype (Wistuba et al., 2001). SCLC accounts sia, though they failed to develop NE lung tumors (Williams et
for about 20% of all lung cancers, while the other, more heterog-
al., 1994).
enous group of non-small cell lung cancers (NSCLC) accounts
To study the role of Rb1 and p53 in the development offor 80%. SCLCs express markers of NE differentiation, whereas
SCLC, we used the Cre-loxP system to obtain lung epithelium-most NSCLCs lack these properties (Rom et al., 2000). SCLC
specific deletion of Rb1 and Trp53 genes. Lungs of mice car-metastasizes early and widely, accounting for the extremely
rying conditional Rb1 and Trp53 alleles (Vooijs et al., 1998;poor prognosis of this tumor (Junker et al., 2000). Whereas
Jonkers et al., 2001) were infected with Adeno-Cre (Ad-Cre)SCLC often initially responds well to chemotherapy, relapses
virus via intratracheal injection (Meuwissen et al., 2001). Somaticoccur almost without exception, and they are usually resistant
inactivation of both Rb1 and Trp53 alleles in a range of proliferat-to cytotoxic treatment (Sandler, 2003). No unequivocal preneo-
ing airway epithelial and alveolar type II cells lead to the develop-plastic lesions have been associated with SCLC (Wistuba et al.,
ment of multiple tumors with histopathology and immunopheno-2001). Mutations commonly found during the pathogenesis of
type closely mirroring human SCLC. These tumors diffuselylung cancer are inactivation of Rb1 and Trp53; indeed, these
are identified in up to 90% of SCLCs (Gouyer et al., 1998; Sekido invaded the surrounding lung parenchyma and readily metasta-
S I G N I F I C A N C E
Small cell lung cancer (SCLC) is a devastating lethal disease for which no cure is available. This study shows that concomitant loss
of Rb and P53 in mouse lung causes a high incidence of SCLC recapitulating the salient features of human SCLC. The fact that loss
of Rb and p53 in a broad range of epithelial cells gives rise almost exclusively to SCLC suggests that only a subset of cells are
susceptible to transformation by these oncogenic events. These observations open the way to define the target cells and identify
the signaling pathways crucial for SCLC. Furthermore, the high penetrance of murine SCLC will facilitate designing and testing of
new treatment modalities against SCLC.
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Figure 1. Photomicrographs of pulmonary NE ep-
ithelial hyperplasia in Trp53F2-10/F2-10/Rb1F19/F19 mice
A: A hyperplastic focus in the airway 2 months
after Ad Cre revealing marked histologic dyspla-
sia (H&E stain).
B: Extensive proliferation in a bronchial hyper-
plastic lesion indicated by anti-Brdu staining (im-
munoperoxidase stain).
sized to extrapulmonary sites, again very similar to human came moribund. Most of the Trp53F2-10/F2-10;Rb1F19/F19 mice (Table
SCLC. 1) developed multiple independent tumors with a median latency
This tumor, which we designate murine small cell lung carci- of 210 days (Figure 2). Tumor onset and progression in these
noma (MSCLC), constitutes a murine SCLC tumor model. In mice was relatively uniform, with tumors becoming detectable
view of the striking similarities to human SCLC, it is hoped that between 196 and 350 days. However, the median tumor-free
the model will be of value for the testing of chemoprevention survival of Trp53F2-10/;Rb1F19/F19 and Trp53F2-10/F2-10;Rb1F19/ mice
and therapeutic strategies in SCLC. was significantly longer, at 364 and 475 days, respectively. This
demonstrates that combined loss of function of Rb1 and Trp53
Results contributes to lung tumorigenesis in these mice. Moreover, lung
tumors were found in mice with all three genotypes, of which the
Somatic inactivation of Rb1 and Trp53 in lung epithelial majority (27/33) of Trp53F2-10/F2-10;Rb1F19/F19 mice showed almost
cells leads to NE neoplastic lesions exclusively SCLC-like tumors, whereas Trp53F2-10/;Rb1F19/F19
In the light of the frequent inactivation of both Trp53 and Rb1 and Trp53F2-10/F2-10;Rb1F19/ mice often exhibited pulmonary ade-
in various lung cancers, most notably in human SCLC, mice nocarcinomas as well as SCLCs (Table 1). We did not observe
carrying conditional alleles for Rb1 (floxed exon 19) and Trp53 lung tumors in control Rb1F19/F19 mice and only lung adenocarci-
(floxed exons 2–10) were used (Vooijs et al., 1998; Jonkers et nomas in Trp53F2-10/F2-10 mice (Table 1). The Rb1F19/F19 mice were
al., 2001). We administered Ad-Cre virus via either intratracheal monitored for up to 600 days before they were sacrificed. Histo-
injection or intubation (Meuwissen et al., 2001) in order to test logic analysis of the lungs of Trp53F2-10/F2-10;Rb1F19/F19, Trp53F2-10/;
whether the somatic inactivation of Trp53 and Rb1 in pulmonary Rb1F19/F19 and Trp53F2-10/F2-10;Rb1F19/ mice revealed tumors that
epithelial cells can cause neoplasia with features of SCLC. His- were strikingly similar to human SCLC (Junker et al., 2000)
tologic examination of lungs from mice, sacrificed 6–8 weeks (Figure 3). The cells of these tumors, which we designate murine
after Ad-Cre administration, showed the occurrence of multiple small cell lung carcinomas (MSCLC) were small and featured
dysplastic foci of clustering small cells in the bronchial and densely hyperchromatic nuclei with a diffuse chromatin pattern
bronchiolar mucosa in every animal tested (Figure 1A and Table that obscured the nucleolus (Figure 3N). Cytoplasm was poorly
1). BrdU labeling indicated a high mitotic index within these developed, and nuclear molding was commonly present (Figure
lesions (Figure 1B), and immunostaining revealed positivity for 3N). The tumors grew mostly in sheets and generally spread
synaptophysin (Syp) and the neural cell adhesion molecule massively and diffusely through the pulmonary tissues and air
Ncam1 (CD 56), indicating NE differentiation (Ferrari et al., 1999; spaces, eliciting no or hardly any stromal response (shown in
Cavallaro et al., 2001).
Figures 3B and 3M). There was high mitotic activity, with local
These results are in accordance with earlier observations in
fields of necrosis, and pronounced angioinvasion was present
lungs of 6-month-old Trp53/;Rb1/ mice (Williams et al.,
in some of the larger tumors. The MSCLCs lacked the typical1994), which also showed NE lesions in the airways. Interest-
glandular and tubular features of mouse adenocarcinomas. Iningly, these lesions invariably showed loss of the wild-type Rb1
a few mice (2/33), adenocarcinomas were however also identi-allele (Williams et al., 1994). In our case, PCR analysis for Rb1
fied, in addition to the MSCLCs. Several mice (6/33) developedand Trp53 recombination in microdissected specimens showed
medullary thyroid carcinomas, which had probably been in-that both Trp53 and Rb1 alleles were inactivated in 4 out of 4
duced by inadvertent spreading of Ad-Cre virus into the thyroidlesions investigated (results not shown). Apart from the focal
gland from the intratracheal injection site. Interestingly, theNE proliferations, no other lesions were observed (Table 1),
MSCLCs arising in Trp53F2-10/F2-10;Rb1F19/F19 mice (14/33) metasta-although Ad-Cre virus infection almost certainly will have inacti-
sized to a range of extrapulmonary sites, such as the bone,vated both Trp53 and Rb1 in a broad range of different lung
brain, adrenal gland, ovary, and liver (Figures 3G–3K, respec-epithelial cells (Meuwissen et al., 2001). However, no obvious
tively). Like the primary tumors (Figure 3D), the metastases ex-effect on Clara cell or alveolar type II cell proliferation was seen.
pressed thyroid transcription factor 1 (TITF1-1) (Ordonez, 2000;
Wu et al., 2003), and their morphological appearance was identi-High incidence of metastasizing NE lung tumors
cal to that of the primary lung tumors. In contrast, only a fewfrom somatic mutation of p53 and Rb1
metastases were associated with the small cell lung tumors fromAd-Cre-treated Trp53F2-10/F2-10;Rb1F19/F19, Trp53F2-10/;Rb1F19/F19,
and Trp53F2-10/F2-10;Rb1F19/ mice were sacrificed when they be- Trp53F2-10/F2-10;Rb1F19/ (2/6), and none were found in Trp53F2-10/;
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Table 1. Occurrence of lung tumors in conditional mutant mice
# of mice sacrificed with
Total number described pathology/# Lesion latency
Genotype of mice of mice analyzed Histopathology of lung lesions in days
RbF19/F19 8 0/8a No lesions, normal
p53F2-10/F2-10 7 1/7a Alveolar adenomatous hyperplasia 140d
6/7b Adenocarcinomas 350–530d
p53F2-10/ 6 6/6b Adenocarcinomas 360–490d
RbF19/F19;p53F2-10/ 13 5/13b Large SCLCs with sporadic adenocarcinomas 308-497d
2/13b Only medullary thyroid carcinomas 322–350d
1/13b Only adenocarcinomas 588d
5/13b No lesions 71–280d
RbF19/;p53F2-10/F2-10 11 3/13b Small SCLCs 392–584d
1/13b Small SCLCs and single adenocarcinomas 455d
1/13b Small SCLCs and metastases in mediastinum and ovary 520d
1/13b Small SCLCs and metastasis in adrenal gland 400d
1/13b Only adenocarcinomas 331d
6/13b No lesions 45–203d
RbF19/F19;p53F2-10/F2-10 4a 3/4 NE hyperplasia (56–84d)
1/4 No lesions
7a 5/7 NE hyperplasia and NE bronchial dysplasia (105–175d)
1/7 NE bronchial dysplasia and metastases in mediastinum
1/7 NE bronchial dysplasia and adenocarcinoma
33b 2/33 Small SCLC and metastases in mediastinum 196–350d
4/33 Small SCLC and lymph vessel invasion
1/33 Small SCLC and bronchioalveolar carcinoma
1/33 Large SCLC and bronchioalveolar carcinomas
14/33 NE hyperplasia, large SCLCS and various metastases
6/33 Large SCLCS with independent medullary thyroid carcinomas
4/33 Only large SCLCS
1/33 Only medullary thyroid carcinomas
The total number of mice analyzed for each genotype and the occurrence of neuroendocrine and other lung lesions at different time points is presented.
Time ranges for sacrifices are indicated in parentheses.
a Mice arbitrarily sacrificed.
b Mice sacrificed when symptoms occurred or died of age.
Rb1F19/F19 mice (Table 1). This is probably due to the long time Trp53F2-10/F2-10;Rb1F19/F19 mice (Figure 4A, lanes 10–13). All (3/5)
Trp53F2-10/;Rb1F19/F19 derived tumors that were analyzed had lostperiod required to form primary tumors precluding the formation
of metastases. No difference in tumor occurrence or phenotype the wild-type Trp53 allele through loss of heterozygosity (Figure
was found between female and male mice of the same com- 4A, lanes 1–3). Two MSCLC tumors from Trp53F2-10/F2-10;Rb1F19/
pound genotype. mice that could be analyzed (out of six total) had lost the wild-
In a search for further evidence of phenotypic parallels with type Rb1 allele (Figure 4A, lanes 14 and 15). MSCLCs rapidly
human SCLC, we evaluated the expression of a variety of epithe- proliferated upon subcutaneous grafting in BalbCnu/nu mice. Sub-
lial and NE markers. Markers that are positive in human SCLC sequent analysis of the transplanted tumors more clearly estab-
and that were also detectable in our murine tumors included lished the loss of both wild-type Rb1 and Trp53 alleles that was
Syp, neural cell adhesion molecule (Ncam1) (Cavallaro et al., suggested by the analysis of the primary tumors (Figure 4B).
2001) (Figures 3E, 3F, and 3I), calcitonin-gene related peptide One Trp53F2-10/F2-10;Rb1F19/ mouse had both adenocarcinomas
(Cgrp) (Shibayama et al., 2001), and neuron-specific enolase and MSCLCS. To test whether the floxed Trp53 and Rb1 alleles
(Kobayashi et al., 1999) (data not shown). were lost in the morphologically different lesions (Figures 5A
and 5B), we performed PCR analysis on DNA extracted from
microdissected MSCLC and adenocarcinoma tissue as well asLoss of heterozygosity of both Rb1 and Trp53
in murine NE lung tumor formation from the adjacent normal lung tissue. We found that in both
lesions, both Trp53 alleles were inactivated. However, in theThe increased median survival of mice with Trp53F2-10/;Rb1F19/F19
and Trp53F2-10/F2-10;Rb1F19/ genotypes as compared with adenocarcinoma lesion, the wild-type Rb1 allele was retained,
which was in striking contrast to the MSCLC, in which the floxedTrp53F2-10/F2-10;Rb1F19/F19 mice indicates that Rb1 and p53 act syn-
ergistically as tumor suppressors for the emergence of murine Rb1 allele was lost through LOH (Figures 5C and 5D). Similar
analyses of two individual single MSCLC lesions in two indepen-lung tumors with SCLC phenotype. To further substantiate this
finding, we analyzed the MSCLCs from all three genotypes for dent Trp53F2-10/F2-10;Rb1F19/ mice gave identical results with re-
spect to loss of the wild-type Rb1 allele (data not shown). Thesethe loss of Rb1 and Trp53 alleles. Southern blot analysis indi-
cated that all primary small cell lung tumors from Trp53F2-10/F2-10; results strongly suggest that p53 inactivation alone is associated
with adenocarcinoma phenotype, but that development ofRb1F19/F19 mice that were analyzed had undergone Cre-mediated
deletion of all four conditional alleles (Figure 4A, lanes 4–9). The MSCLC with its characteristic morphology and neural pheno-
type is dependent on the inactivation of both Rb1 and Trp53.same holds for the different liver metastases from the individual
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Figure 2. Incidence of NE lung tumors in mice carrying conditional Rb1 and
Trp53 alleles
Kaplan-Meier lung tumor free mouse survival curve of Trp53F2-10/F2-10;
Rb1F19/F19, Trp53F2-10/;Rb1F19/F19, and Trp53F2-10/F2-10;Rb1F19/ mice. The median time
of survival (T50) of the Trp53F2-10/F2-10;Rb1F19/F19 mice is 210 days. For Trp53F2-10/;
Rb1F19/F19 and Trp53F2-10/F2-10;Rb1F19/ mice, T50 is 364 and 475 days, respectively.
Tumors from each genotype are indicated by different colors. Mice were
killed when having severe breathing problems combined with weight loss.
All mice had substantial lung tumor load and a subgroup of mice also had
primary medullary thyroid carcinomas (see Table 1).
NE differentiation is associated
with high Ascl1 expression
A key marker for human SCLCs is the expression of human
achaete-scute complex homolog-like 1 (ASCL1) (Borges et al.,
1997; Garber et al., 2001; Bhattacharjee et al., 2001). The ex-
pression of the murine counterpart of ASCL1 was only found in
clustered pulmonary NE cells or neuroendocrine bodies (NEBs)
(Wuenschell et al., 1996; Ito et al., 2000). It has been shown
that the expression of this basic helix-loop-helix transcription
Figure 3. Photomicrographs of NE lung tumors from mice carrying Trp53 and
factor determines the onset and maintenance of NE differentia- Rb1 alleles
tion in normal pulmonary epithelial cells and also in lung tumors Representative lesions are shown from mice after 225–310 days after Ad-
Cre treatment.with NE features (Ball et al., 1993; Borges et al., 1997).
A: Massive infiltration of lung lobe by MSCLC. Tumors show vascularizationSince our primary MSCLCs as well as their metastases were
and small areas of necrosis and massive infiltration into the surrounding lung
strikingly similar to human SCLC, we immunostained serial sec- parenchyma (H&E staining).
tions of the murine lesions for Ascl1 and the NE markers Cgrp B: Part of the tumor protrudes to bronchiolar lumen (arrow) (H&E staining).
C: Lymphangitic spread (arrows) and an intraluminal component of MSCLCand Syp. Morphologically unremarkable NEBs stained very
(H&E staining); T  tumor.strongly for Cgrp and Syp, while Ascl1 staining was less intense. D–F: Immunostaining of MSCLC with antisera raised against Titf1 (D), Ncam1
Ninety percent of focal NE cell proliferations in the lung were (E) and Syp (F). Infiltrating lymphocytes are negative for Titf1 (D).
G–L: MSCLC metastasis into the medullary cavity of the breastbone (G).positive for Cgrp or synaptophysin (Syp), while 65% were posi-
Metastasis into (H) forebrain cortex, (I) adrenal gland, revealing Syp immu-tive for Ascl1 with or without Syp or Cgrp (Figures 6A–6C). Only
noreactivity and surrounded by negative adrenal cortex, (J) ovary, and
a small fraction (7%–11%) was exclusively positive for Ascl1 (K–L) liver, with or without immunostaining for Syp.
M: Tumor tissue engulfing and surrounding small airway and adjacent pul-but negative for both other markers. Tumors and hyperplasias
monary blood vessel, without eliciting fibrotic stromal response.stained more intensely for Ascl1 (Figure 7A) than the regular
N: High-power field of tumor cells, which feature finely dispersed chromatin.
NEBs. Primary tumors (Figures 7A–7D) and liver metastases Cytoplasm is scanty and is morphologically featureless, and there is charac-
(Figures 7E–7G) were generally positive for all markers. teristic molding of nuclei of adjacent tumor cells.
Some of the tumors were also positive for Scgb1a1, the
Clara cell secretory protein, a marker of the nonciliated secretory
(Clara) cells. The liver metastases were all negative for Scgb1a1. Discussion
These results indicate close resemblance between murine small
cell lung tumors and human SCLCs in having high Ascl1 expres- Since high mutation frequencies of tumor suppressor genes
sion activity associated with neural and NE differentiation and Rb1 and Trp53 have been observed in human SCLCs (Minna
et al., 2002; Sattler and Salgia, 2003), inactivation of Rb1 andmaintenance of neuronal markers.
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Figure 4. Trp53 and Rb1 gene inactivation in NE
lung tumors
A: Southern blots of tumor DNA to detect Cre-
mediated inactivation of Trp53 (BglII digestion,
Trp53 XbaI probe) and Rb1 (PstI digestion, Rb1
PvuII probe). Representative tumors and control
tissues (tail) are shown for each genotype.
Numbers under each lane denote individual
mice. Arrows indicate the bands corresponding
to the different alleles. All NE lung tumors from
Trp53F2-10/F2-10;Rb1F19/F19 mice show Cre-mediated
deletion of all four conditional alleles. NE lung
tumors from Trp53F2-10/;Rb1F19/F19 and Trp53F2-10/F2-10;
Rb1F19/ mice, show in addition to Cre-mediated
loss of the floxed Trp53 and Rb1 alleles, invariable
loss of the wild-type (wt) Trp53 and Rb1 alleles.
In all tumor DNA samples, the remaining hybrid-
ization signals are most likely derived from normal
contaminating tissue, as indicated by equal in-
tensities of the flox/wt and  bands for Trp53 and
Rb1, respectively; C  control tail DNA from
Trp53F2-10/F2-10;Rb1F19/F19 mice.
B: Samples of primary tumors were transplanted
in Balbcnu/nu mice for further tumor propagation
with less contamination of normal tissue. Num-
bers under each lane correspond to the tumors
from each individual mouse in A. As can be seen,
level of contamination is far less and it is very likely
that the primary tumors #3 and #15 originally did
have LOH for wt Trp53 and Rb1 alleles, respec-
tively.
Trp53 seemed a logical approach for establishing a mouse highly prone to SCLC development but that progression re-
quires additional, more rarely occurring genetic lesions. Alterna-model for SCLC. Introduction of both Rb1 and Trp53 lesions
into pulmonary epithelial cells via mouse germ line mutations tively, some of these neoplastic lesions might originate from
specific cell types that have limited capacity to progress to overtis precluded by the embryonic lethality of Rb1 null mutants. So
far, only mild bronchial and bronchiolar NE cell hyperplasia was tumors. Second, NE lung tumors from Trp53F2-10/;Rb1F19/F19
showed LOH of the remaining wild-type allele, and third,found in Rb1/;Trp53/ mice (Williams et al., 1994), without
progression to a fully malignant phenotype possibly as a result Trp53F2-10/F2-10;Rb1F19/ mice only developed MSCLC upon loss
of the wt Rb allele; when the wt Rb allele was retained, adenocar-of the strong predisposition to other tumors in the Trp53-null
background. We therefore decided to use the Cre-loxP system cinomas ensued. Finally, the median latency period of NE lung
tumor formation in Trp53F2-10/F2-10;Rb1F19/F19 mice is significantlyfor introducing Rb1 and Trp53 mutations somatically in a broad
range of lung epithelial cells. In a relative short time-span after reduced as compared to Trp53F2-10/;Rb1F19/F19 and Trp53F2-10/F2-10;
Rb1F19/ mice. Single Trp53F2-10/F2-10 mice yielded only lung ade-lung epithelial cells were infected with Ad-Cre virus, we ob-
served small foci of NE cell proliferation in airways, and in these, nocarcinomas with similar morphology and tumor latency as
seen in Trp53/ mice (Donehower, 1996). We could not detectboth alleles of Rb1 and Trp53 were inactivated. These lesions
progressed to dysplasias and histologically malignant lung tu- any lung tumors in Rb1F19/F19 mice up to 18 months after Ad-
Cre treatment, nor could we find any hyperproliferative NE cellmors, displaying NE differentiation and SCLC morphology.
These tumors, which we accordingly designated mouse small foci in the airways at earlier time points in these mice. Loss of
Rb1 by itself is therefore insufficient to induce NE neoplasia,cell lung carcinomas (MSCLCs), were highly proliferative, inva-
sive, and had a marked capacity to metastasize to liver, brain, and further progression might require the suppression of p53-
mediated apoptosis. Interestingly, loss of Rb1 function seemsadrenal gland, bone, and ovaries. Taken together, histopathol-
ogy, immunophenotype, and patterns of growth and dissemina- to be crucial in permitting the proliferation of cells expressing
the NE differentiation program. Accordingly, no tumors with NEtion of MSCLC are indeed strikingly similar to human SCLC.
Our data show unambiguously that Rb1 and p53 act syner- features are found when a functional Rb1 allele is retained.
This is not unexpected, since loss of Rb1 appears particularlygistically as tumor suppressors in mouse NE tumor formation
and that the loss of both Rb1 and Trp53 is therefore a prerequi- predominant in tumors that derive from neural or NE cells: med-
ulloblastoma, pituitary tumors, retinoblastoma, and PNETs (Ma-site for NE lung tumor formation. First, Cre-mediated biallelic
deletion of Trp53 and Rb1 is found in all NE lung tumors from rino et al., 2000; Wechsler-Reya and Scott, 2001; Vooijs et al.,
1998; Classon and Harlow, 2002; Brodeur, 2003). This is in lineTrp53F2-10/F2-10;Rb1F19/F19 mice. At the same time, however, the
focal proliferative lesions could persist as such, since sporadic with the continued expression of neuronal markers including
ASCL1 in the majority of the tumors (Ball et al., 1993). The bHLHNE proliferative foci were still detected in mice already having
substantial tumor load and even metastases. This might indicate transcription factor ASCL1 is expressed both in normal NEBs
and in SCLC (Ball et al., 1993; Borges et al., 1997). Repressionthat loss of Rb1 and p53 leads to a population of cells that is
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Figure 5. Correlation of histopathology with Cre-mediated Rb1 and Trp53 allelic recombination and loss of wt Rb1 allele in a Trp53F2-10/F2-10/Rb1F19/ mouse
A: Immunostaining for the NE marker Syp in MSCLC lesion in part of lung lobe.
B: Lack of immunostaining for Syp in an adenocarcinoma from another lung lobe of the same mouse. Tumor morphologies are markedly different, and
only the MSCLC lesion has NE features.
C: PCR-based analysis of Trp53 and Rb1 allelic recombination. DNA was isolated from paraffin sections following microdissection of independent tumors
from each mouse as indicated. DNA from adjacent normal lung from each mouse served as control tissue. Lanes Sc show PCR fragments using DNA from
the MSCLC lesion (a), and lanes Ac show PCR products from the adenocarcinoma lesion (b), both from identical mouse with indicated genotype, Trp53F2-
10/F2-10;Rb1F19/, above lanes. A 212 bp PCR product represents the floxed, unrecombined Trp53F2-10 alleles, whereas the 168 bp fragment represents a
recombined, deleted Trp53F2-10 allele and a 130 bp fragment corresponds to the wt Trp53 allele. For Rb1 allelic recombination, a 283-, 260-, and 235-bp
product corresponds to the floxed, the recombined, and wt Rb1 allele, respectively. DNA fragments for Trp53 recombination show only the 168 bp fragment,
meaning that in the control tumors as well as lesion (a and b), all Trp53 alleles are inactivated. For the DNA fragments corresponding to Rb1 recombination,
this holds true for all the control tumor lesions and the small cell tumor lesion (a). The adenocarcinomas lesion, however, still has a wt Rb1 allele retained
producing a 235 bp fragment.
of ASCL1 leads to loss of NE differentiation in human SCLC that in CGRP-Hras mice, expression of Hras in pulmonary NE
epithelial cells caused only bronchial adenocarcinomas, evencultures (Borges et al., 1997), underlining its pivotal role in estab-
lishment and maintenance of the NE differentiation phenotype. though CGRP-Hras lost its activity in fully developed adenocar-
cinomas. This suggests an active repression of neuronal differ-The expression pattern of Ascl1 in early NE hyperplasia and in
primary NE lung tumors in our mutants suggests that entiation in the original NE target cells by an active Ras pathway
(Sunday et al., 1999). In contrast, the loss of both Rb1 andRb119;Trp532-10 tumors originated from progenitors of pulmonary
NE cells. However, since not all neural tumors express this Trp53 seems to impose or allow for the maintenance of NE
differentiation and proliferation.marker, it is more probable that it serves as a marker of cell of
origin or lineage than that its expression is directly or indirectly Considering the variety of markers that are expressed in our
MSCLC, we favor a model in which different progenitors of theregulated by Rb1, even though Rb1 may be involved in modulat-
ing the expression of a suppressor of Ascl11, Hes1 (Lasorella NE lineage can serve as cells of origin for SCLC. Some of
these progenitors might also serve as precursors of Clara cells.et al., 2000; Jogi et al., 2002; Toma et al., 2000). Previous studies
showed that somatic activation of Kras2 in the same pulmonary Indeed, there is evidence that injured or depleted Clara cells
can be replaced from common precursors for both Clara andepithelial target cells generates only pulmonary adenocarcino-
mas (Meuwissen et al., 2001; Jackson et al., 2001). Thus, two NE cells (Reynolds et al., 2000a, 2000b). This pool of precursor
cells might be widely present throughout the airway epitheliummorphologically distinct tumor types result from the different
genetic lesions that are introduced. Most likely, identical lesions and thus serve as a plausible target for Ad-Cre virus infection.
Primary NE tumors derived from these common precursor cellsexhibit strong cell type-dependent effects, leading to transfor-
mation of divergent target cells. For instance, Kras2 would then could then partially retain SCGB1A1 expression, as we ob-
served. This also argues for an earlier progenitor or lung epithe-have a profound different effect in pulmonary NE cells as com-
pared to alveolar type II cells. Alternatively, different lesions lial stem cell being the target cell that gives rise to MSCLC. A
recent study provided further support for this by showing thatmight drive the same target cells into a dissimilar path of differ-
entiation. In favor of the latter possibility is the observation a similar pattern of sonic hedgehog (SHH) signaling observed
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Figure 6. Pulmonary NE cell hyperplasia Figure 7. NE differentiation in primary and metastatic MSCLC
Serial sections were obtained from a Trp53F2-10/F2-10;Rb1F19/F19 mouse, 11 weeks
Serial sections were obtained from a Trp53F2-10/F2-10;Rb1F19/F19 mouse, 36 weeks
after Ad-Cre treatment.
after Ad-Cre treatment.
A: Hyperplastic lesions reveal strong nuclear staining for Ascl1, while most A: A primary MSCLC reveals strong nuclear immunostaining for Ascl1, while
of the epithelium lining the bronchial lumen is negative. Scattered cells
the epithelium lining the airway lumen is negative.
express Ascl1 (arrows). B: The same tumor is strongly positive for anti-Cgrp staining which shows a
B: Cytoplasmic Cgrp immunostaining in scattered epithelial cells (arrows)
cytoplasmic pattern. The airway epithelium remains negative.
and in the larger lesion on the right. C: Positive immunostaining for Syp, also with a cytoplasmic pattern. A few
C: Two large areas of Syp-positive hyperplasias of the epithelium. Lu 
positive nerve fibers can be seen below the unstained epithelium (arrows).
lumen. D: Airway epithelium is strongly positive for Scgb1a1 (arrows) together with
scattered tumor cells. Bronchiolar lumen (Lu), vessel (Ve), and tumor (Tu).
E: Anti-Ascl1 staining showing nuclear positivity in a liver metastasis from the
same mouse, surrounded by parenchyma revealing lace-like planes of
unstained liver cells.in NE precursor cells was also found in a subset of human
F: The same lesion was positive for Cgrp, whereas liver cells remained nega-SCLCs and that an active SHH pathway is crucial in maintaining
tive.
proliferation and NE differentiation in SCLC (Watkins et al., G: Anti-Syp staining surrounded by negative liver cells. Metastasis (Met) and
2003). vessel (Ve).
The early NE progenitor cells would only require loss of Rb1
to secure proliferation of this particular cell type without the
need for additional loss of p130 or p107 function. In contrast,
Experimental proceduresthe functional redundancy of all three pocket proteins (Lipinski
and Jacks, 1999; Dannenberg et al., 2000; Sage et al., 2000)
Intratracheal Adeno-Cre virus administrationis probably effective in non-NE pulmonary epithelial cells along
One series of mice was infected with Ad-Cre virus by an injection into thethe airways, thus explaining the massive adenocarcinomas seen
trachea as described in previous study (Meuwissen et al., 2001), whereas
in CC10-SV40Tag (Magdaleno et al., 1997; Linnoila et al., 2000) another series was intratracheally intubated.
and their almost complete absence in Trp53F2-10/F2-10;Rb1F19/F19
mice. Genotyping of mice
The model presented in this study shows that somatic inacti- We detected the Trp53F2-10 allele by PCR amplification of the loxP site in
intron 10, yielding products of 584 bp and 431 bp for the floxed and wild-vation of both Rb1 and Trp53 alleles in lung epithelial cells
type alleles using primers p53-10F (5- AAGGGGTATGAGGGACAAGG-3)readily leads to formation of small cell NE tumors. Since their
and p53-10R (5-GAAGACAGAAAAGGGGAGGG-3). Detection of thehistopathologic characteristics and metastasizing capacity are
Trp532-10 allele yielded a 612 bp fragment using primers p53-10F and p53-strikingly similar to human SCLCs, we have termed them
10R. The Rb1F19 allele was detected using primers Rb18 (5-GGCGTGTGCCAMSCLC. Our model may prove a valuable tool for (1) comparing
TCAAT-3) and Rb19 (5-AACTCAAGGGAGACCTG-3) yielding products of
genotype-phenotype similarities between human SCLC and
650 and 490 bp for the floxed and wild-type alleles, respectively. For all
MSCLC, (2) the identification of precursor lesions and (3) addi- PCR reactions, thermocyling conditions consisted of 30 cycles of 30 s at
tional factors involved in tumor progression, and (4) ultimately, 95C, 30 s at 58C, and 50 s at 72C. Reactions contain approximately 200
testing of targeted, novel tumor intervention strategies and ng of template DNA, 0.5 M primers, 100 M dNTPs, 2.5 U of Taq DNA
polymerase, 2.5 mM MgCl2, and 1 PCR buffer in a 25 l volume.chemoprevention.
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